Skip to main content



 

Long-Acting Drug Delivery Formulations


Engineering, testing, and validation of microparticles and implants/devices for the controlled release of various therapeutic agents over extended periods of time (weeks to months and years); preformed and in-situ formed biodegradable implants; new methods for biodegradation and biocompatibility characterizations; not-biodegradable implants.


Poster # First Name Last Name Abstract Title Abstract
100 Marco Block Miniaturized screening and tailoring of preclinical formulations for subcutaneous extended-release View
146 Pacome Andele Human mature omental adipocytes used as reservoir for paclitaxel delivery to ovarian tumor organoids. View
280 Elena Lagreca Peptide nanocomplexes for mRNA delivery through microparticles-based microneedles. View
360 Alessandro Grattoni Modulating the tumor immune microenvironment via controlled intratumoral immunotherapy delivery for local and abscopal cancer treatment View
395 Magdy Abdelquader A novel thermal analysis-based approach for quantitative determination of THEDES in THEDES/polymer mixtures View
396 Masoud Adhami Antibiotic-Loaded 3D-Printed Implantable Devices: A Prophylactic Measure against Post-Surgical Infections View
397 Edouard Badarau A new generation of bola-amphiphiles as key components of sustained-release drug delivery systems View
398 Saurabh Bhorkade Understanding the Influence of PLGA Residual Content on In Vitro performance of Risperidone Microsphere View
399 Bianca Brandl 3D-Printing of Subcutaneous Implantable Drug Delivery Systems with Patient-Tailored Long-Term Release Profiles View
400 Francesco Cancilla Development of hybrid hydrogel based on waterborne polyurethane and hyaluronic acid as bioresponsive platform for locoregional anticancer drugs delivery View
401 Hunter Chen Highly tunable release of proteins from crosslinked PEG hydrogels View
402 Daniela Cruz Effects of Drug-to-Excipient Ratio in Release Kinetics of Antiretrovirals in a Long-Acting Biodegradable Subcutaneous Implant. View
403 Frederic Dargelas In-vivo near zero-order release kinetics of a 3-month long-acting silica biodegradable injectable depot of Cyanocobalamin View
406 Mauro Di Stefano A biorelevant analytical toolbox to enable developability assessment of thermosensitive drug delivery systems for biologics View
407 Nicola Di Trani Subdermal long-acting islatravir nanofluidic implant achieves viral load reduction in SHIV-infected non-human primates View
408 Peter Dijkshoorn Determination of total API content in polymeric sustained release formulations by CHN elemental analysis. View
410 Mikhail Durymanov Modification of mesenchymal stromal cells with silibinin-loaded PLGA nanoparticles improves their therapeutic efficacy for cutaneous wound repair View
411 Agnese Fragassi Injectable Hyaluronic Acid Microparticles for Sustained Lubrication and Cartilage Protection in Osteoarthritis View
413 Meliha Gunes Development Of Core-Shell Structure Electrospun Fibers from Emulsions View
414 Marcus Gutmann Matrix Metalloproteinase-Responsive Delivery of PEGylated Fibroblast Growth Factor 2 View
415 Sarah Anne Howard Effect of Drug Physiochemical Properties on Long-Acting Release for Injectable, Reversible Male Contraception View
416 Michaela Hrochová HPMA-based polymer diblock structures for drug delivery View
417 Sarika Jadhav Sirolimus loaded polymeric micro/nano particles coated long acting stent: Profiling in vitro release View
420 Swetha Kodamasimham Codelivery of STING Agonist & Manganese from Injectable PLGA Implants for Enhanced Cancer Immunotherapy View
421 Olga Lem The role of lipid oxidation pathway in reactive oxygen species-mediated cargo release from liposomes View
422 Giuditta Leone Design of a long-acting vasodilator nanomedicine for inhalation in pulmonary arterial hypertension View
424 Fang Liu Combination Therapies Using a New Controlled Delivery Technology BEPO® in Melanoma Treatment in Mice View
425 Nileshkumar Malavia Formulation Insights into Long-Acting Hormonal Contraceptives for Advancing Generic Drug Development View
426 Dalila Miele Characterization of the end phase degradation of PLGA, PLGA/PLA implants as biodegradable drug delivery systems View
427 Takumi Mitsuoka Development of an implantable sustained-release device View
428 Heejun Park Design of experiments (DoE) approach to optimize supercritical fluid extraction of emulsion (SFEE) process for preparation of peptide-loaded sustained-release PLGA microsphere View
429 Charlotte Peloso Evaluation of minipig injection sites for subcutaneous administration of in situ forming depot formulations View
430 Mikayla Rahman Melt-cast Microneedle Patches for Long-acting Contraceptive Delivery View
432 Mckenzie Roy Investigating the impact of risperidone CQAs on the in vitro release of in situ forming implants View
433 Ishmamul Sadab Protein nanosheets for prolonged and localized display of therapeutic proteins in tumor microenvironment. View
434 Lakshmi Sathi Devi Viscoelastic injectable hydrogel loaded with hydrophobic and hydrophilic drugs for combinatorial cancer therapy. View
435 Deborah Shalev Immiscible-Compatible TSPU/PLLA Polymer Films as Drug-Eluting Delivery Systems View
436 Caroline Sousa Characterizing the antimalarial profile of decoquinate and initial development of drug nanocrystals towards increasing its biopharmaceutical properties View
438 Maksim Zhelezniakov Polymer excipient analyses: A critical consideration in the development of generic long acting injectables View
439 Rita Vanbever PEGylated elastase-inhibiting single-domain antibody fragment for the local treatment of inflammatory lung diseases View
440 Lucia Vizzoni Development of Pluronic/carboxymethyl chitosan based thermosensitive gel for antigen sustained release in future immunological treatments View
441 Chun Wang Controlled release of vaccines from a hydrophobic liquid polymer depot induces long-lasting antigen-specific humoral and cellular immune responses View
442 Feihu Wang Prodrug hydrogel-based scaffold vaccine for cancer immunotherapy View
443 Cameron White Formulation and Characterization of Composition-equivalent Exenatide-PLGA Microspheres prepared by Coacervation View
542
Nuran Caz Elevated ROS-levels as target for bioresponsive nanocarriers: how cancer can kill itself. View
1072 Wildan Khairi Muhtadi Development of tamsulosin hydrochloride-loaded dissolving microneedles for the management of benign prostatic hyperplasia View
1142
Kara Vine-Perrow Turning up the heat on pancreatic cancer View
1216 Alyssa Kunkel A Modular Microparticle Delivery System to Control Antigen Release Kinetics Aiming to Improve Vaccine Efficacy View



Back to Top